ADVM
Adverum Biotechnologies Inc
Halal Rating :
Last Price
$4.25
Last updated:
Market Cap
-
7D Change
1.19%
1 Year Change
393.44%
Company Overview
Industries
Exchange
Next Earnings Date
Adverum Biotechnologies Inc is a clinical-stage gene therapy company focusing on developing treatments for serious rare and ocular diseases. The company's lead product candidate is ixoberogene soroparvovec (Ixo-vec), which targets wet age-related macular degeneration (wet AMD). The company utilizes its proprietary vector development platform to create novel gene therapy product candidates.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $1.0m | $30.22m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Adverum Biotechnologies Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.